Middle East respiratory syndrome coronavirus (MERS-CoV) – Qatar

On 21 February 2016, the National IHR Focal Point of Qatar notified WHO of 1 additional case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. A 66-year-old, male, Qatari national developed symptoms on 18 February while in Saudi Arabia, where he had stayed for approximately 2 months. On 19 February, the patient sought health care in a hospital in El-Hassa Region, Saudi Arabia, where he was treated symptomatically and discharged. The patient developed additional symptoms on 20 February. On the same day, as his condition deteriorated, the patient was transferred by ambulance to a hospital in Doha, Qatar. The patient, who was a heavy smoker and had comorbidities, tested positive for MERS-CoV on 21 February. He passed away on 7 March.
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: coronavirus [subject], coronavirus infections, coronavirus [subject], coronavirus infections, coronavirus [subject], coronavirus infections, hygiene [subject], disinfection, disinfect, risk assessment [subject], Disease outbreak news [doctype], Eastern Me Source Type: news

Related Links:

tinez “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)”, the novel coronavirus, is responsible for the ongoing worldwide pandemic. “World Health Organization (WHO)” assigned an “International Classification of Diseases (ICD)” code—“COVID-19”-as the name of the new disease. Coronaviruses are generally transferred by people and many diverse species of animals, including birds and mammals such as cattle, camels, cats, and bats. Infrequently, the coronavirus can be transferred from animals to humans, and then propagate am...
Source: Sensors - Category: Biotechnology Authors: Tags: Article Source Type: research
COVID-19 is caused by the Severe Acute Respiratory Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus with a positive-polarity, single-stranded RNA genome. The initial outbreak of the pandemic began in December 2019, and it is affecting the human health of the global community. In common with previous pandemics (Influenza H1N1 and SARS-CoV) and the epidemics of Middle east respiratory syndrome (MERS)-CoV, CoVs target bronchial and alveolar epithelial cells. Virus protein ligands (e.g., haemagglutinin or trimeric spike glycoprotein for Influenza and CoV, respectively) interact with cellular receptors, such as (dependin...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Coronaviruses are pathogens that target the human respiratory system. Previous outbreaks of coronaviruses include severe acute respiratory syndrome (SARS) [1] and Middle East respiratory syndrome (MERS) [2]. In December, 2019, an outbreak of pneumonia of unknown cause was reported in Wuhan, China [3]. Chinese scientists rapidly identified the causative agent as a novel coronavirus (SARS-CoV-2) by sequencing the complete genome from lower respiratory tract samples of patients in Wuhan [4]. The WHO named this disease “coronavirus disease 2019” (COVID-19).
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: COVID-19 Rapid Letter Source Type: research
CONCLUSION: Lung function abnormalities, psychological impairment and reduced exercise capacity were common in SARS and MERS survivors. Clinicians should anticipate and investigate similar long-term outcomes in COVID-19 survivors. PMID: 32449782 [PubMed - as supplied by publisher]
Source: Journal of Rehabilitation Medicine - Category: Rehabilitation Tags: J Rehabil Med Source Type: research
This study reviewed the state-of-the-art techniques for CoV prediction algorithms based on data mining and ML assessment. The reliability and acceptability of extracted information and datasets from implemented technologies in the literature were considered. Findings showed that researchers must proceed with insights they gain, focus on id entifying solutions for CoV problems, and introduce new improvements. The growing emphasis on data mining and ML techniques in medical fields can provide the right environment for change and improvement.
Source: Journal of Medical Systems - Category: Information Technology Source Type: research
This study showed that a five-day regimen is as effective as 10 days–that’s important, doctors say, since it could mean shorter stays in the hospital, which could alleviate some of the burden on the health care system. “Of course we will have to wait for the final review of all the data, but it would be very nice to have an anti-viral that’s efficacious in this terrible illness,” says Dr. Aruna Subramanian, a clinical professor of medicine at Stanford and an investigator on the study. “At least we know that we can help patients with this, and that’s really the bottom line.” T...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 feature Magazine Source Type: news
This article is protected by copyright. All rights reserved. PMID: 32438473 [PubMed - as supplied by publisher]
Source: European Journal of Immunology - Category: Allergy & Immunology Authors: Tags: Eur J Immunol Source Type: research
This article is protected by copyright. All rights reserved. PMID: 32437587 [PubMed - as supplied by publisher]
Source: European Journal of Immunology - Category: Allergy & Immunology Authors: Tags: Eur J Immunol Source Type: research
I live-tweeted a fascinating and perhaps rather depressing meeting with William Haseltine via a Reuters Newsmaker Broadcast. His talk was upbeat but the message does not offer a positive outlook unless we can collaborate internationally to identify, trace, and isolate and go back to early antivirals to treat people urgently. A vaccine will probably never be found, we must stay on top of this virus when we get communities under control. Moreover, we must recognise that another emergent pathogen could appear any time. These are essentially my notes from Haseltines’s talk. Might we ever achieve herd immunity? There is n...
Source: David Bradley Sciencebase - Songs, Snaps, Science - Category: Science Authors: Tags: Sciencebase Source Type: blogs
I live-tweeted a fascinating and perhaps rather depressing meeting with William Haseltine via a Reuters Newsmaker Broadcast. His talk was upbeat but the message does not offer a positive outlook unless we can collaborate internationally to identify, trace, and isolate and go back to early antivirals to treat people urgently. A vaccine will probably never be found, we must stay on top of this virus when we get communities under control. Moreover, we must recognise that another emergent pathogen could appear any time. These are essentially my notes from Haseltines’s talk. Might we ever achieve herd immunity? There is n...
Source: David Bradley Sciencebase - Songs, Snaps, Science - Category: Science Authors: Tags: Sciencebase Source Type: blogs
More News: Coronavirus | Health | Health Management | Hospitals | Infectious Diseases | MERS | Middle East Health | Outbreaks | Qatar Health | Respiratory Medicine | Smokers